Evidence map›Paper›PMID 33410350›Full record

ArticleLeukemia & lymphoma2021

Shiqiang Qu, Yujiao Jia, Huijun Wang, Xiaofei Ai, Zefeng Xu, Tiejun Qin, Lijuan Pan, Bing Li, Gang Huang, Robert Peter Gale and 1 more

Open access · greenAbstract readLetter
In one paragraph

Article in Leukemia & lymphoma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Recurrent Missense Driver STAT5BAnti-cancer agents in medicinal chemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Shiqiang QuMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Yujiao JiaNational Clinical Research Centre for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Huijun WangNational Clinical Research Centre for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Xiaofei AiNational Clinical Research Centre for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Zefeng XuMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Tiejun QinMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Lijuan PanMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Bing LiMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Gang HuangDivisions of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Robert Peter GaleHaematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Zhijian XiaoMDS and MPN Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNInstitute of Hematology & Blood Diseases Hospital · CNCincinnati Children's Hospital Medical Center · USImperial College London · GB

Funding

Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic SyndromesR01DK105014 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI HUANG, GANG · 2015 to 2019
$1.8M
Department of HealthNIDDK NIH HHS R01 DK105014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Large Granular LymphocyticNeoplasmsHumansMutationSTAT3 Transcription FactorSTAT5 Transcription FactorT-LymphocytesSTAT3 protein, humanSTAT3 Transcription FactorSTAT5B protein, humanSTAT5 Transcription Factor

Identifiers

PMID33410350
PMCPMC9204507
OpenAlexW3120898993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.